Papers

2

Total Citations

26

H-Index

2

About

Michael Ehmann is a researcher specializing in stereotactic body radiation therapy (SBRT) and brachytherapy, with a focus on motion management and treatment planning for liver and prostate cancers. His major contributions include demonstrating that liver SBRT with active motion-compensation achieves excellent local control for oligometastases, as shown in his highly cited 2021 pooled multi-platform cohort study (21 citations). This work has significant implications for improving outcomes in patients with limited liver metastases. Ehmann also advanced robotic low-dose rate brachytherapy by developing a treatment planning system that integrates multiple-direction needle-path planning with inverse dose optimization, enabling more conformal dose delivery while avoiding critical risk structures (2021, 5 citations). His innovative approaches to motion compensation and automated planning enhance precision and safety in radiotherapy. Ehmann’s research bridges technical optimization and clinical application, making him a notable contributor to modern radiation oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
26
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases: An outcome analysis of a pooled multi-platform patient cohort
21 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: University Medical Centre Mannheim, Heidelberg University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago